Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMID 17294322)

Published in Dis Colon Rectum on April 01, 2007

Authors

Steve Heymen1, Yolanda Scarlett, Kenneth Jones, Yehuda Ringel, Douglas Drossman, William E Whitehead

Author Affiliations

1: UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. steve_heymen@med.unc.edu

Articles citing this

American Gastroenterological Association technical review on constipation. Gastroenterology (2013) 3.27

Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging (2010) 2.08

Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99

Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. Am J Gastroenterol (2010) 1.88

Dyssynergic defecation and biofeedback therapy. Gastroenterol Clin North Am (2008) 1.59

Biofeedback therapy for dyssynergic defecation. World J Gastroenterol (2006) 1.09

Diagnosis and treatment of pelvic floor disorders: what's new and what to do. Gastroenterology (2010) 1.06

Chronic constipation: current treatment options. Can J Gastroenterol (2011) 1.05

Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut (2010) 1.01

Efficacy of biofeedback plus transanal stimulation in the management of pelvic floor dyssynergia: a randomized trial. Tech Coloproctol (2015) 1.01

Biofeedback therapy for constipation in adults. Best Pract Res Clin Gastroenterol (2011) 1.00

Medical and surgical management of pelvic floor disorders affecting defecation. Am J Gastroenterol (2012) 0.99

Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment). World J Gastroenterol (2012) 0.96

The Long-term Clinical Efficacy of Biofeedback Therapy for Patients With Constipation or Fecal Incontinence. J Neurogastroenterol Motil (2010) 0.96

Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool. J Neurogastroenterol Motil (2013) 0.95

Treatment of obstructed defecation. Clin Colon Rectal Surg (2012) 0.92

Epidemiology and management of chronic constipation in elderly patients. Clin Interv Aging (2015) 0.91

Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction. Int Urogynecol J (2010) 0.90

Discriminative value of anorectal manometry in clinical practice. Dig Dis Sci (2008) 0.89

Psychological treatments in functional gastrointestinal disorders: a primer for the gastroenterologist. Clin Gastroenterol Hepatol (2012) 0.89

Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut (2015) 0.89

Prucalopride: the evidence for its use in the treatment of chronic constipation. Core Evid (2008) 0.87

A randomized controlled trial of anorectal biofeedback for constipation. Int J Colorectal Dis (2011) 0.86

Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument. Clin Gastroenterol Hepatol (2009) 0.86

Functional Anorectal Disorders. Gastroenterology (2016) 0.85

Predictive capability of anorectal physiologic tests for unfavorable outcomes following biofeedback therapy in dyssynergic defecation. J Korean Med Sci (2010) 0.85

Biofeedback for the treatment of female pelvic floor muscle dysfunction: a systematic review and meta-analysis. Int Urogynecol J (2012) 0.84

Treating pelvic floor disorders of defecation: management or cure? Curr Gastroenterol Rep (2009) 0.83

Technique of functional and motility test: how to perform biofeedback for constipation and fecal incontinence. J Neurogastroenterol Motil (2013) 0.82

Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis. J Neurogastroenterol Motil (2016) 0.82

All Roads Lead to Rome: Update on Rome III Criteria and New Treatment Options. Gastroenterol Rep (2007) 0.82

ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil (2015) 0.82

Understanding and treating refractory constipation. World J Gastrointest Pharmacol Ther (2014) 0.79

The effect of biofeedback therapy on dyssynergic constipation in patients with or without Irritable Bowel Syndrome. J Res Med Sci (2014) 0.79

Diagnosis and Treatment of Dyssynergic Defecation. J Neurogastroenterol Motil (2016) 0.78

Successful outcome of refractory chronic constipation by surgical treatment: a series of 34 patients. J Neurogastroenterol Motil (2013) 0.78

Biofeedback-guided pelvic floor exercise therapy for obstructive defecation: an effective alternative. World J Gastroenterol (2014) 0.77

Balloon expulsion testing for the diagnosis of dyssynergic defecation in women with chronic constipation. Int Urogynecol J (2015) 0.77

Current Trends in Management of Defecatory Dysfunction, Posterior Compartment Prolapse, and Fecal Incontinence. Curr Obstet Gynecol Rep (2016) 0.75

Habit training versus habit training with direct visual biofeedback in adults with chronic constipation: study protocol for a randomised controlled trial. Trials (2017) 0.75

Biofeedback therapy in constipation and fecal incontinence. J Neurogastroenterol Motil (2010) 0.75

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition. J Neurogastroenterol Motil (2016) 0.75

Anorectal biofeedback for neurogenic bowel dysfunction in incomplete spinal cord injury. Spinal Cord (2016) 0.75

Patient considerations in the management of chronic constipation: focus on prucalopride. Patient Prefer Adherence (2016) 0.75

Abdominal Symptoms Are Common and Benefit from Biofeedback Therapy in Patients with Dyssynergic Defecation. Clin Transl Gastroenterol (2015) 0.75

Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice. Curr Gastroenterol Rep (2017) 0.75

Biofeedback therapy for chronic constipation in a patient with Prader-Willi syndrome. Ann Gastroenterol (2015) 0.75

Functional Disorders of Constipation: Paradoxical Puborectalis Contraction and Increased Perineal Descent. Clin Colon Rectal Surg (2017) 0.75

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly. Clin Interv Aging (2013) 0.75

Efficacy of Adaptive Biofeedback Training in Treating Constipation-Related Symptoms. Evid Based Complement Alternat Med (2015) 0.75

Rectosigmoid Localization of Radiopaque Markers Does Not Correlate with Prolonged Balloon Expulsion in Chronic Constipation: Results from a Multicenter Cohort. Am J Gastroenterol (2015) 0.75

MR defecography: a diagnostic test for the evaluation of pelvic floor motion in patients with dyssynergic defecation after biofeedback therapy. Med J Islam Repub Iran (2015) 0.75

Efficacy of Cranial Electrotherapy Stimulation Combined with Biofeedback Therapy in Patients with Functional Constipation. J Neurogastroenterol Motil (2016) 0.75

Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis. Neurogastroenterol Motil (2015) 0.75

Biofeedback treatment of chronic constipation: myths and misconceptions. Tech Coloproctol (2016) 0.75

Management of chronic constipation in adults. United European Gastroenterol J (2016) 0.75

Articles by these authors

Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03

Prevalence of symptomatic pelvic floor disorders in US women. JAMA (2008) 7.81

Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15

AGA technical review on irritable bowel syndrome. Gastroenterology (2002) 6.76

The transcriptional and epigenomic foundations of ground state pluripotency. Cell (2012) 5.87

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology (2003) 3.77

Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology (2006) 2.98

The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93

Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol (2011) 2.83

Design of treatment trials for functional gastrointestinal disorders. Gastroenterology (2006) 2.58

Endoscopic third ventriculostomy and choroid plexus cauterization in infants with hydrocephalus: a retrospective Hydrocephalus Clinical Research Network study. J Neurosurg Pediatr (2014) 2.27

Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat Med (2009) 2.26

Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum (2009) 2.24

Digestive and liver diseases statistics, 2004. Gastroenterology (2004) 2.14

Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome. Am J Gastroenterol (2010) 2.12

Fetoscopic Repair of Meningomyelocele. Obstet Gynecol (2015) 2.07

Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology (2005) 2.05

"Keystone" approach for intracranial nasofrontal dermoid sinuses. Plast Reconstr Surg (2005) 1.89

Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study. J Clin Gastroenterol (2011) 1.88

Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol (2008) 1.85

Increased somatic complaints and health-care utilization in children: effects of parent IBS status and parent response to gastrointestinal symptoms. Am J Gastroenterol (2004) 1.82

Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe (2012) 1.81

Publication patterns of oral and poster presentations at the annual meetings of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons. J Neurosurg (2011) 1.73

IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol (2011) 1.72

Risk factors for fecal incontinence in older women. Am J Gastroenterol (2012) 1.64

Cognitive-behavioral therapy for children with functional abdominal pain and their parents decreases pain and other symptoms. Am J Gastroenterol (2010) 1.54

Posterior reversible encephalopathy syndrome during posterior fossa tumor resection in a child. J Neurosurg Pediatr (2010) 1.52

Computed tomography morphometric analysis for C-1 lateral mass screw placement in children. Clinical article. J Neurosurg Pediatr (2009) 1.52

Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49

Intraoperative monitoring of motor evoked potentials in very young children. J Neurosurg Pediatr (2011) 1.46

Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol (2007) 1.44

Management of shunt infections: a multicenter pilot study. J Neurosurg (2006) 1.43

Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence. Dis Colon Rectum (2005) 1.43

Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One (2012) 1.41

Effectiveness of a clinical pathway for patients with cerebrospinal fluid shunt malfunction. J Neurosurg Pediatr (2010) 1.40

Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut (2007) 1.39

Extracranial traumatic carotid artery dissections in children: a review of current diagnosis and treatment options. J Neurosurg Pediatr (2008) 1.39

Patients and nonconsulters with irritable bowel syndrome reporting a parental history of bowel problems have more impaired psychological distress. Dig Dis Sci (2004) 1.39

Complementary and alternative medicine use and cost in functional bowel disorders: a six month prospective study in a large HMO. BMC Complement Altern Med (2008) 1.33

Validation of a measure of protective parent responses to children's pain. Clin J Pain (2006) 1.31

Structural modeling of dynamic changes in memory and brain structure using longitudinal data from the normative aging study. J Gerontol B Psychol Sci Soc Sci (2004) 1.29

Fecal incontinence in primary care: prevalence, diagnosis, and health care utilization. Am J Obstet Gynecol (2010) 1.29

What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol (2007) 1.29

Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol (2008) 1.29

Hypnosis treatment for severe irritable bowel syndrome: investigation of mechanism and effects on symptoms. Dig Dis Sci (2002) 1.28

Routine imaging in patients with ventriculopleural shunts: lessons learned from a case of tension hydrothorax. J Neurosurg Pediatr (2008) 1.27

A multicenter retrospective comparison of conversion from temporary to permanent cerebrospinal fluid diversion in very low birth weight infants with posthemorrhagic hydrocephalus. J Neurosurg Pediatr (2009) 1.25

Alterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndrome. Gastroenterology (2003) 1.23

Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology (2007) 1.22

Irritable bowel syndrome subtypes defined by Rome II and Rome III criteria are similar. J Clin Gastroenterol (2009) 1.20

Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci (2009) 1.19

Bowel symptoms in women 1 year after sacrocolpopexy. Am J Obstet Gynecol (2007) 1.19

Recommendations for probiotic use-2011 update. J Clin Gastroenterol (2011) 1.19

Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds. Bioorg Med Chem Lett (2008) 1.18

Prebiotics and the health benefits of fiber: current regulatory status, future research, and goals. J Nutr (2012) 1.17

Biofeedback treatment of constipation: a critical review. Dis Colon Rectum (2003) 1.17

Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog (2010) 1.17

Catastrophizing and Parental Response to Child Symptom Complaints. Child Health Care (2009) 1.16

Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med (2007) 1.15

Computed tomography morphometric analysis for translaminar screw fixation in the upper thoracic spine of the pediatric population. J Neurosurg Pediatr (2011) 1.14

Anorectal functional testing: review of collective experience. Am J Gastroenterol (2002) 1.13

The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12

Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology (2009) 1.11

Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J Agric Food Chem (2004) 1.11

Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index. J Gastroenterol (2006) 1.11

Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. J Nutr (2005) 1.09

Subject's Global Assessment of Relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. J Clin Epidemiol (2003) 1.08

Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women. Am J Gastroenterol (2002) 1.08

Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls. Clin J Pain (2010) 1.07

Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J Psychosom Res (2013) 1.07

Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome. J Gastroenterol Hepatol (2012) 1.07

Relationship between the decision to take a child to the clinic for abdominal pain and maternal psychological distress. Arch Pediatr Adolesc Med (2006) 1.07

Surgeons as medical school educators: an untapped resource. Anat Sci Educ (2011) 1.06

Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. J Agric Food Chem (2003) 1.06

Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology (2010) 1.05

Periosteal chondroma of the pediatric cervical spine. J Neurosurg Pediatr (2009) 1.05

Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med (2011) 1.04

Intestinal microbiota in healthy U.S. young children and adults--a high throughput microarray analysis. PLoS One (2013) 1.04

A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative. J Neurosurg Pediatr (2011) 1.04

The role of biofeedback in the treatment of gastrointestinal disorders. Nat Clin Pract Gastroenterol Hepatol (2008) 1.04

Bowel symptoms in women planning surgery for pelvic organ prolapse. Am J Obstet Gynecol (2006) 1.02

Biofeedback treatment for functional anorectal disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback (2004) 1.02

Teaching diaphragmatic breathing for rumination syndrome. Am J Gastroenterol (2006) 1.02

Association of low dietary intake of fiber and liquids with constipation: evidence from the National Health and Nutrition Examination Survey. Am J Gastroenterol (2013) 1.00

Solid variant of aneurysmal bone cyst of the thoracic spine: a case report. J Med Case Rep (2011) 1.00

Risk factors for urinary, fecal, or dual incontinence in the Nurses' Health Study. Obstet Gynecol (2013) 0.98

A clinicopathologic correlation in osteoblastoma of the spine in a child. J Clin Neurosci (2011) 0.98

Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. J Agric Food Chem (2005) 0.98

Anti-enteric neuronal antibodies and the irritable bowel syndrome. J Neurogastroenterol Motil (2012) 0.98

Unexplained gastrointestinal symptoms after abuse in a prospective study of children at risk for abuse and neglect. Ann Fam Med (2010) 0.97

Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. Dig Dis Sci (2003) 0.97

Cognitive mediators of treatment outcomes in pediatric functional abdominal pain. Clin J Pain (2014) 0.97